This serine analog contains a cyclohexyl ether substituent that enhances steric mass and modulates polarity. The Fmoc protection facilitates controlled incorporation into peptide frameworks. Researchers employ it to examine hydrogen-bonding modulation and conformational restriction. Its hydrophobic substituent supports exploration of membrane-associated environments.
CAT No: R2181
CAS No:221057-20-1
Synonyms/Alias:221057-20-1;N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-cyclohexyl-L-serine;N-alpha-(9-Fluorenylmethyloxycarbonyl)-O-cyclohexyl-L-serine //;CS-0120121;G81888;EN300-6513030;(2S)-3-(cyclohexyloxy)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid;
2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.